Sites / National Heart Institute
Is this you?

Request access for National Heart Institute with your @nationalheartinstitute.org work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

National Heart Institute

Unclaimed profile

Independent Site · Beverly Hills, California · ~1 sites

Intera lens
ICP 7Lift (cardio sample) 0.29Recruit soph 0.71
Quality Scorecard (1–100)
Overall92Recruit85Ops92Sponsor96Ther98

Performance (observed)

Historical trials
800
Completed
451
Terminated/Withdrawn
58
Completion rate
89%
Active now
261
Phase 2
193
Phase 3
374
Realized enrollment
937,299
First study year
1981
Years active
45
Match confidence
low (approx)
Enrollment velocity (inf)
20,829

Therapeutic

Areas
Cardiovascular diseases, Heart failure, Coronary artery disease, Hypertension, Metabolic disorders, Diabetes, Obesity, Chronic kidney disease
Specialties
Cardiovascular, metabolic (heart failure, CAD, hypertension, cholesterol, obesity, diabetes, CKD, arrhythmias)
Breadth (conditions)
1,453
Languages
English + Spanish (detected)
States
California

Recruitment (web observed)

Meta Pixel
Yes
Facebook Ads
Yes
Patient database
Y
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y - active blog with cardiovascular research articles
Capability notes
Active patient recruitment with emphasis on underserved communities; free participation with compensation and transportation support

Relationships

Sponsors
Children's Oncology Group; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); Pfizer; Eli Lilly and Company; Novo Nordisk A/S
CROs
ICON plc; IQVIA Commercial GmbH & Co. OHG; IQVIA Pvt. Ltd; MacroGenics; MicroPort CRM; Worldwide Clinical Trials
Owner / parent
Founded/led by Dr. Norman Lepor (Cedars-Sinai affiliated)

Capacity & people

Investigators
Coordinators
CEO
Dr. Norman Lepor
VP Clinical Ops
Maria Flores (Director, Clinical Trial Operations)
Emails
mflores@nationalheartinstitute.org

Tech & DCT

Builds tech
Vendors (research data management systems)
Tech stack
Clinical research databases; emphasis on patient safety monitoring and protocol adherence tracking
Recruiting visible
Y

Notes

Strong cardiovascular and metabolic disease focus with 7 active recruiting cardiometabolic trials (ClinicalTrials.gov validation). Founder-led, physician-directed research site with 30+ years clinical research experience. Emphasis on patient accessibility and enrollment in underserved populations. Single location but strong recruitment capabilities and therapeutic focus align with Intera ICP. Score reflects: strong recruitment narrative, cardiometabolic specialization, and physician leadership; limited by single-site constraint.

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.29Overall92

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.